Dr. Zhao Zhang

Principal Investigator (PI) in Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University.

Experience

1. Ph.D., Bioinformatics, Fudan University (2016)

2. Postdoc, University of Texas Health Science center at Houston (UThealth, 2021)

Research Interests

We focus on dynamic alterations of regulatory elements in large-scale cohorts and complex diseases using cutting-edge bioinformatics algorithms and biotechnologies.

Recent research includes:

1. Characterizing regulatory elements, such as eRNAs and histone modifications, across species, tissues, and cancer types, and uncovering their potential utility in clinical treatments (Nature Commutations, 2019; Nucleic Acids Research 2021, 2022; Cancer Research, 2022, Advanced Science, 2023).

2. Utilizing pan-cancer analysis to understand key factors in tumorigenesis and aid in drug development (The Innovations, 2023; Genome Medicine, 2020; RNA Biology, 2019; Communications Biology, 2018; Clinical epigenetics, 2021).

We have been invited to contribute reviews, commentaries, and spotlights to multiple journals, including Nature Biotechnology, Trends in Genetics, Trends in Molecular Medicine, Trends in Cancers and Oncogene. To date, we have published approximately 50 peer-reviewed papers with a total citation count nearing 2000.